Drug News: Finacea, FluMist, IntanzaFinacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Celiac disease: the stealthy robber of healthThere are many myths and misconceptions surrounding celiac disease. Dealing with grievances under new regulations With regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). Pharmacy technician training: A Quebec college certificate? Montreal-based Dawson College is working with various partners on a new continuing education (CE) program for pharmacy technician training. Research Highlights: Drug-eluting stents - duration of dual antiplatelet therapy Percutaneous coronary intervention is a procedure used to treat the stenotic coronary arteries found in coronary heart disease. Letter: What do pharmacists want? Why are we providing our professional services for less than it costs to cover our expenses? Editorial: How do you like your innovation? In these uncertain times, be open to new ideas, wherever they originate. Medication Forum: SGLT2 inhibitors for type 2 diabetes The potential role of SGLT2 inhibitors in the management of type 2 diabetes. Other opportunities enabling expanded scopes of practice Beyond the provision of prescriptive privileges. Clinical Notes: New vitamin D guidelines Osteoporosis Canada updates recommendations for optimal vitamin D intake. First Previous 2109 2110 2111 2112 2113 Next Last
